Basic information
- Standard SMILES
O=P(O)(O)OC[C@H]1O[C@@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O- InChIKey
RNBGYGVWRKECFJ-ZXXMMSQZSA-N- Molecular formula
- C6H14O12P2
- Average molar mass
- 340.12 g/mol
Overview
Alpha-D-fructofuranose 1,6-bisphosphate is a D-fructofuranose 1,6-bisphosphate with an alpha-configuration at the anomeric position. It is functionally related to an alpha-D-fructofuranose. It is a conjugate acid of an alpha-D-fructofuranose 1,6-bisphosphate(4-).
Names & identifiers
- Preferred name
- Fructose-1,6-Diphosphate
- IUPAC
- [(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate
Names & synonyms
fructose-1,6-diphosphateFructose 1,6-diphosphate[(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate((2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl)methyl dihydrogen phosphateSr-FDPRefChem:600595GlyTouCan:G18745STstrontium fructose-1,6-diphosphateG18745STANW5CM3PJ7alpha-D-FosfructofuranoseUNII-ANW5CM3PJ7
Show more names
NSC-575531,6-di-O-phosphono-alpha-D-fructofuranoseCHEMBL1089962alpha-D-Fructofuranose 1,6-diphosphatealpha-D-fructofuranose 1,6-bisphosphatealpha-D-Fructofuranose, 1,6-bis(dihydrogen phosphate)fructose-1,6-bisphosphateAFP
Database identifiers
- CAS
34693-23-7- PubChem CID
- 445557
- ChEMBL
CHEMBL1089962- ChEBI
CHEBI:40595- UNII
- ANW5CM3PJ7
- Nikkaji
- J792.775D
Properties
Computed structural properties
- XLogP
- -5.6
- Topological polar surface area
- 203 Ų
- Hydrogen bond donors
- 7
- Hydrogen bond acceptors
- 12
- Rotatable bonds
- 6
- Heavy atoms
- 20
- Formal charge
- 0
- Complexity
- 428
Experimental & physicochemical properties
Collision Cross Section168.2 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
Chemistry & industry
Pharmacology
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.
Biologically active substances whose activities affect or play a role in the functioning of the immune system.
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
Related reactions
3 records
Linked notes
Loading…